Guaifenesin Tablet, Extended Release
Product Images NDC 41415-996

2 FDA label images from Publix Super Markets, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 41415-996). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Publix Super Markets, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Publix-600mg-spl-1 (Publix 600mg Spl 1)

Publix-600mg-spl-1 (Publix 600mg Spl 1)
12-Hour mucus relief Guaifenesin extended-release tablets, 600 mg oral expectorant by Publix Super Markets, Inc. The label shows a package containing 20 extended-release tablets. Key information includes chest congestion relief and mucus thinning properties. An image of the tablet with imprint RH98 is shown at actual size.*
FDA Label Image

Publix-600mg-spl-2 (Publix 600mg Spl 2)

Publix-600mg-spl-2 (Publix 600mg Spl 2)
Drug Facts panel for GUAIFENESIN extended-release 600 mg tablet. The text shows the active ingredient and purpose, usage instructions, warnings including age restrictions and when to consult a doctor, directions for use, storage information, tamper-evident packaging notice, and inactive ingredients. The label is distributed by Publix Super Markets, Inc and includes barcodes and contact details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.